vision!!

Since the AGM our Board has doubled in size and we have had three Chairmen in the last twelve months.
No new initiative to progress the fortunes for the technology or CZD has occurred since the AGM. We are now to vote for the granting of 10m options to the current Chairman, David Williams, without hearing his vision for CZD or a programme set by the Board for the commercialization of the Polynovo technology or the future for Metabolic. I am abstaining from voting at this EGM, because as shareholders I believe we have been short changed by our Board about where CZD is heading.